You are here

BPX-501

Bellicum Pharmaceuticals Rakes in $69 Million - Closes Public Offering

Flag link:

Bellicum Shares Up After Clinical Hold lifted on BPX-501

Bellicum Shares Up After Clinical Hold lifted on BPX-501

CP Wire

clinical trials

Flag link:

Bellicum Shares Up After Clinical Hold lifted on BPX-501

Flag link:

Bellicum Pharmaceuticals Faces Clinical Hold After Three Patients Suffer Brain Damage

Bellicum Pharmaceuticals Faces Clinical Hold After Three Patients Suffer Brain Damage

Xtalks

clinical trials

hematologic cancers

Flag link:

Bellicum Therapy Reduces Risk from Mismatched Stem Cell Transplants

Bellicum Therapy Reduces Risk from Mismatched Stem Cell Transplants

TheStreet.com

Flag link: